Skip to main navigation Skip to search Skip to main content

Trastuzumab for the treatment of HER2-positive metastatic adenocarcinoma of the stomach or gastro-oesophageal junction.

  • G. Norman
  • , S. Rice
  • , E. Spackman
  • , L. Stirk
  • , A. Danso-Appiah
  • , D. Suh
  • , S. Palmer
  • , A. Eastwood
  • University of York

Research output: Contribution to journal › Review article › peer-review

14 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Trastuzumab for the treatment of HER2-positive metastatic adenocarcinoma of the stomach or gastro-oesophageal junction.'. Together they form a unique fingerprint.
Sort by

Nursing and Health Professions

Pharmacology, Toxicology and Pharmaceutical Science